Test ID BLOD0453 Smith-Lemli-Opitz Screen, Plasma
Reporting Name
Smith-Lemli-Opitz Scrn, PUseful For
Diagnosing Smith-Lemli-Opitz syndrome (7-dehydrocholesterol reductase deficiency)
Performing Laboratory
Mayo Clinic Laboratories in RochesterSpecimen Type
PlasmaNecessary Information
Biochemical Genetics Patient Information (T602) is recommended, but not required, to be filled out and sent with the specimen to aid in the interpretation of test results.
Specimen Required
Collection Container/Tube:
Preferred: Green top (sodium or lithium heparin)
Acceptable: Lavender top (EDTA), pearl white top (EDTA plasma gel), yellow top (ACD solution A or B)
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions:
1. Centrifuge and aliquot plasma into plastic vial.
2. Send plasma frozen.
Specimen Minimum Volume
0.1 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Plasma | Frozen (preferred) | 92 days | |
Refrigerated | 28 days | ||
Ambient | 14 days |
Reference Values
7-DEHYDROCHOLESTEROL
≤2.0 mg/L
8-DEHYDROCHOLESTEROL
≤0.3 mg/L
Day(s) Performed
Tuesday, Friday
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
82542
Report Available
3 to 7 daysReject Due To
Gross hemolysis | OK |
Gross lipemia | OK |
Gross icterus | OK |
Method Name
Gas Chromatography Mass Spectrometry (GC-MS)
Forms
1. Biochemical Genetics Patient Information (T602)
2. If not ordering electronically, complete, print, and send a Biochemical Genetics Test Request (T798) with the specimen.
Special Instructions
Sanford Interface Build Information
Result Code | Result Code Description |
---|---|
13346 | Smith-Lemli-Opitz Scrn |
13350 | Interpretation |
13348 | Reviewed By |